Opportunity Information: Apply for PAR 21 178

The Drug Development Tools Research Grants (U01) Clinical Trial Optional opportunity (PAR 21 178) is a cooperative agreement program run by the U.S. Department of Health and Human Services, Food and Drug Administration (FDA). Its main aim is to fund research that moves specific drug development tools forward toward formal qualification through an FDA drug development tool qualification program housed in either CDER (Center for Drug Evaluation and Research) or CBER (Center for Biologics Evaluation and Research). A key requirement is that the proposed tool must already be in the FDA qualification pipeline with an accepted Letter of Intent (LOI). In other words, this funding is meant to accelerate and strengthen tools that are already recognized by FDA as candidates for qualification, rather than support brand-new tool concepts that have not entered the qualification process.

The program focuses on developing tools that can make drug development more efficient, more reliable, and better aligned with public health needs. The funded work is intended to generate the evidence, validation, and supporting data needed for a tool to meet FDA qualification standards. Once a tool is qualified, it is expected to be made publicly available so it can be broadly used across the research and development community, helping address unmet needs in drug development rather than benefiting only a single sponsor or proprietary pipeline. The FOA is described as "Clinical Trial Optional," meaning applicants may propose projects that include clinical trial elements if they are necessary for tool development and validation, but a clinical trial is not automatically required.

This opportunity uses the U01 mechanism, which is a cooperative agreement. That matters because it typically involves substantial FDA involvement during the life of the award compared with a standard research grant. In practice, that can include coordination, feedback, and collaborative oversight to help ensure the proposed activities remain aligned with the qualification program expectations and the broader goal of producing a qualified, publicly usable tool. The funding instrument is categorized under discretionary funding, with activity areas spanning consumer protection, food and nutrition, science and technology, and other research and development. The program is listed under CFDA number 93.103.

Eligibility is broad and includes many types of organizations that are capable of conducting this kind of applied, translational research. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other entities as allowed under the FOA's additional eligibility language. This wide eligibility reflects the reality that drug development tool work can be performed by academic groups, nonprofits, consortia, government entities, and industry partners, as long as the work supports the public, precompetitive goal of a qualified and publicly available tool.

In terms of timing and scale, the FOA was created on February 18, 2021, with application due dates on May 25, 2021; May 3, 2022; and May 3, 2023 (each by 11:59 PM Eastern Time). The original closing date was May 3, 2023. The award ceiling is $250,000, and the opportunity anticipated making about 30 awards. Overall, the program is designed to support multiple projects that collectively strengthen the ecosystem of qualified drug development tools by funding the focused research and validation activities needed to complete the pathway from accepted LOI to eventual qualification and broad public availability.

  • The Department of Health and Human Services, Food and Drug Administration in the consumer protection, food and nutrition, science and technology and other research and development sector is offering a public funding opportunity titled "Drug Development Tools Research Grants (U01) Clinical Trial Optional" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103.
  • This funding opportunity was created on Feb 18, 2021.
  • Applicants must submit their applications by May 03, 2023 Application Due Date(s)May 25, 2021 by 1159 PM Eastern Time May 3, 2022 by 1159 PM Eastern TimeMay 3, 2023 by 1159 PM Eastern Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $250,000.00 in funding.
  • The number of recipients for this funding is limited to 30 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for PAR 21 178

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: Department of Health and Human Services, Food and Drug Administration

Browse more opportunities from the same category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development

Next opportunity: DoD Peer Reviewed Cancer, Career Development Award

Previous opportunity: Underground Mine Evacuation Technologies and Human Factors Research

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 21 178

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 21 178) also looked into and applied for these:

Funding Opportunity
Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD) (U01) Clinical Trial Required Apply for RFA FD 21 020

Funding Number: RFA FD 21 020
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $1,000,000
Expanding the opioids system modeling efforts to more comprehensively address fentanyl, stimulants use, polysubstance use and associated outcomes.(U01) Clinical Trials Not Allowed Apply for RFA FD 21 022

Funding Number: RFA FD 21 022
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $1,250,000
Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01) Clinical Trials Not Allowed Apply for RFA FD 21 026

Funding Number: RFA FD 21 026
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $600,000
SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed Apply for RFA FD 21 025

Funding Number: RFA FD 21 025
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $450,000
Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional Apply for RFA FD 21 035

Funding Number: RFA FD 21 035
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $2,000,000
Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional Apply for RFA FD 22 003

Funding Number: RFA FD 22 003
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $1,000,000
Deconstruction of data and standards to support harmonization and interoperability with real world data for clinical research and regulatory submissions. (U01 Clinical Trial Not Allowed) Apply for RFA FD 22 022

Funding Number: RFA FD 22 022
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $350,000
Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24) Clinical Trials Not Allowed Apply for RFA FD 23 002

Funding Number: RFA FD 23 002
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $400,000
Centers of Excellence in Regulatory Science and Innovation (CERSI) Apply for RFA FD 23 004

Funding Number: RFA FD 23 004
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Funding Amount: $1,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 178", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: